Medacta Group revenue and financials
In the fiscal year ended December 2025, Medacta Group reported revenue of €683.83M (+15.79% year over year). Net income was €95.46M, a net margin of 14.0%.
Fiscal year ending in December. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +15.79%
- 2025 vs 2024
- Net income growth
- +30.97%
- 2025 vs 2024
- Net margin
- 14.0%
- 2024: 12.3%
How Medacta Group is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 17.7% a year on average over the last 5 years
Compound annual growth rate: from €302.49M in 2020 to €683.83M in 2025.
Revenue has grown for 5 fiscal years in a row
Each fiscal year compared with the one before, up to 2025.
Less cash than profit: free cash flow equal to 25% of net income
Totals for fiscal years 2023–2025: free cash flow €53.06M, net income €215.71M.
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 684 | 591 | 511 | 437 | 363 | 302 | 311 | 273 | 245 | 219 |
| Cost of revenue | 225 | 191 | 163 | 132 | 102 | 88.2 | 86.9 | 68.6 | 62.1 | 54.5 |
| Gross profit | 459 | 399 | 348 | 305 | 261 | 214 | 224 | 204 | 183 | 165 |
| Selling, general and administrative | 321 | 285 | 252 | 220 | 182 | 155 | 176 | 139 | 129 | 113 |
| Research and development | 21.5 | 20.8 | 18.8 | 15.1 | 10.9 | 6.8 | 7.6 | 3.9 | 3.1 | 2.7 |
| Operating income | 115 | 93.4 | 76.5 | 69.5 | 67.1 | 52.8 | 40.1 | 61.7 | 50.4 | 49.9 |
| EBIT | 115 | 93.4 | 76.5 | 69.5 | 67.1 | 52.8 | 40.1 | 61.7 | 50.4 | 49.9 |
| EBITDA | 172 | 143 | 120 | 107 | 97.8 | 82.0 | 66.5 | 84.7 | 71.7 | 67.5 |
| Interest expense | 6.8 | 7.5 | 6.8 | 3.7 | 3.4 | 3.0 | 3.4 | 2.1 | 1.7 | 1.2 |
| Pre-tax income | 115 | 87.8 | 58.7 | 54.8 | 55.5 | 39.9 | 13.6 | 58.0 | 47.4 | 48.6 |
| Income tax | 19.8 | 14.9 | 11.4 | 8.5 | 3.9 | 2.8 | 1.8 | 12.3 | 13.9 | 9.4 |
| Net income | 95.5 | 72.9 | 47.4 | 46.2 | 51.5 | 37.1 | 11.9 | 45.8 | 33.5 | 39.2 |
| Net income to common shareholders | 95.5 | 72.9 | 47.4 | 46.2 | 51.5 | 37.1 | 11.9 | 45.8 | 33.5 | 39.2 |
| Basic EPS | 4.79 | 3.66 | 2.37 | 2.32 | 2.58 | 1.85 | 0.59 | 2.29 | 837.07 | 980.08 |
| Diluted EPS | 4.78 | 3.65 | 2.37 | 2.31 | 2.58 | 1.85 | 0.59 | 2.29 | 837.07 | 980.08 |
| Average shares (basic) | 19.9 | 19.9 | 20.0 | 20.0 | 20.0 | 20.0 | 20.0 | 20.0 | 0.0 | 0.0 |
| Average shares (diluted) | 20.0 | 20.0 | 20.0 | 20.0 | 20.0 | 20.0 | 20.0 | 20.0 | 0.0 | 0.0 |
| Dividend per share | 1.18 | 0.74 | 0.59 | 0.55 | 0.52 | — | — | — | — | — |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 368 | 340 | 344 | 302 | 289 | 256 | 255 | 226 | 211 | 186 |
| Cost of revenue | 128 | 116 | 109 | 100 | 90.9 | 83.7 | 79.3 | 69.0 | 62.9 | 53.0 |
| Gross profit | 241 | 224 | 236 | 202 | 198 | 172 | 176 | 157 | 148 | 133 |
| Selling, general and administrative | 174 | 158 | 162 | 142 | 142 | 129 | 123 | 113 | 107 | 96.5 |
| Research and development | 12.3 | 10.0 | 11.5 | 10.8 | 10.0 | 9.7 | 9.1 | 7.6 | 7.5 | 6.4 |
| Operating income | 55.0 | 54.2 | 62.4 | 47.9 | 45.5 | 32.8 | 43.8 | 35.7 | 33.7 | 29.0 |
| EBIT | 55.0 | 54.2 | 62.4 | 47.9 | 45.5 | 32.8 | 43.8 | 35.7 | 33.7 | 29.0 |
| EBITDA | 97.5 | 74.9 | 98.8 | 65.1 | 77.5 | 47.8 | 71.9 | 48.9 | 58.1 | 41.2 |
| Interest expense | 4.8 | 7.4 | 13.3 | 10.2 | 8.6 | 2.7 | 9.5 | 3.6 | 5.8 | 4.6 |
| Pre-tax income | 51.3 | 46.7 | 68.6 | 43.1 | 44.7 | 22.5 | 36.2 | 24.3 | 30.5 | 23.9 |
| Income tax | 9.4 | 11.3 | 8.6 | 8.2 | 6.7 | 4.3 | 7.1 | 3.6 | 4.9 | 2.1 |
| Net income | 41.9 | 35.4 | 60.0 | 34.9 | 38.0 | 18.2 | 29.1 | 20.6 | 25.6 | 21.8 |
| Net income to common shareholders | 41.9 | 35.4 | 60.0 | 34.9 | 38.0 | 18.2 | 29.1 | 20.6 | 25.6 | 21.8 |
| Basic EPS | 2.10 | 1.78 | 3.01 | 1.75 | 1.91 | 0.91 | 1.46 | 1.03 | 1.28 | 1.09 |
| Diluted EPS | 2.10 | 1.77 | 3.01 | 1.75 | 1.90 | 0.91 | 1.46 | 1.03 | 1.28 | 1.09 |
| Average shares (basic) | 19.9 | 19.9 | 19.9 | 19.9 | 19.9 | 19.9 | 20.0 | 20.0 | 20.0 | 20.0 |
| Average shares (diluted) | 20.0 | 20.0 | 20.0 | 20.0 | 19.9 | 20.0 | 20.0 | 20.0 | 20.0 | 20.0 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 918 | 792 | 696 | 584 | 489 | 442 | 413 | 366 | 300 | 270 |
| Current assets | 450 | 395 | 348 | 284 | 228 | 218 | 188 | 175 | 139 | 129 |
| Cash and equivalents | 33.2 | 31.6 | 20.8 | 32.3 | 20.4 | 48.1 | 27.2 | 33.7 | 25.1 | 20.7 |
| Receivables | 133 | 119 | 101 | 85.2 | 67.3 | 51.1 | 55.5 | 48.2 | 39.8 | 38.1 |
| Inventory | 271 | 234 | 214 | 160 | 136 | 114 | 102 | 89.2 | 72.5 | 67.4 |
| Net property, plant and equipment | 386 | 318 | 267 | 218 | 180 | 153 | 157 | 133 | 102 | 101 |
| Goodwill | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | — |
| Other intangible assets | 14.4 | 12.9 | 13.5 | 14.4 | 16.0 | 16.8 | 18.3 | 19.1 | 17.7 | 4.6 |
| Current liabilities | 217 | 158 | 149 | 89.1 | 137 | 145 | 121 | 114 | 92.1 | 60.3 |
| Accounts payable | 49.8 | 35.4 | 38.9 | 28.5 | 26.0 | 16.5 | 17.8 | 20.1 | 17.3 | 16.5 |
| Long-term debt | 114 | 143 | 116 | 138 | 49.6 | 65.0 | 85.4 | 107 | 50.3 | 12.9 |
| Total debt | 263 | 244 | 204 | 172 | 135 | 150 | 153 | 164 | 97.8 | 41.9 |
| Total liabilities | 461 | 413 | 366 | 310 | 263 | 277 | 289 | 277 | 198 | 123 |
| Total equity (incl. minority) | 457 | 380 | 330 | 275 | 226 | 165 | 123 | 89.1 | 102 | 147 |
| Retained earnings | 434 | 351 | 282 | 240 | 192 | 139 | 103 | 93.0 | 113 | 143 |
| Minority interest | — | — | — | 0.0 | 0.0 | — | — | — | — | — |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1,008 | 918 | 861 | 792 | 732 | 696 | 645 | 584 | 551 | 489 |
| Current assets | 496 | 450 | 442 | 395 | 364 | 348 | 322 | 284 | 263 | 228 |
| Cash and equivalents | 36.0 | 33.2 | 33.2 | 31.6 | 16.4 | 20.8 | 27.7 | 32.3 | 22.2 | 20.4 |
| Short-term investments | — | — | 7.4 | — | — | — | — | — | — | — |
| Receivables | 139 | 133 | 118 | 119 | 104 | 101 | 104 | 85.2 | 88.5 | 67.3 |
| Inventory | 297 | 271 | 267 | 234 | 224 | 214 | 186 | 160 | 152 | 136 |
| Net property, plant and equipment | 425 | 386 | 343 | 318 | 292 | 267 | 245 | 218 | 206 | 180 |
| Goodwill | — | 0.1 | — | 0.1 | — | 0.1 | — | 0.1 | — | 0.1 |
| Other intangible assets | 67.4 | 14.4 | 54.7 | 12.9 | 49.7 | 13.5 | 49.9 | 14.4 | 51.8 | 16.0 |
| Current liabilities | 236 | 217 | 185 | 158 | 166 | 149 | 125 | 89.1 | 95.2 | 137 |
| Accounts payable | 60.4 | 49.8 | 51.0 | 35.4 | 44.1 | 38.9 | 40.7 | 28.5 | 30.8 | 26.0 |
| Long-term debt | 159 | 114 | 138 | 143 | 125 | 116 | 131 | 138 | 131 | 49.6 |
| Total debt | 321 | 263 | 255 | 244 | 231 | 204 | 197 | 172 | 169 | 135 |
| Total liabilities | 525 | 461 | 436 | 413 | 388 | 366 | 347 | 310 | 299 | 263 |
| Total equity (incl. minority) | 483 | 457 | 425 | 380 | 344 | 330 | 298 | 275 | 252 | 226 |
| Retained earnings | 451 | 434 | 398 | 351 | 314 | 282 | 264 | 240 | 220 | 192 |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 153 | 107 | 75.1 | 73.5 | 54.1 | 59.6 | 42.6 | 66.4 | 51.6 | 56.3 |
| Depreciation and amortization | 66.4 | 57.0 | 49.8 | 43.1 | 35.3 | 33.8 | 30.8 | 23.0 | 21.3 | 17.6 |
| Capital expenditure | -123 | -89.3 | -69.7 | -58.4 | -46.5 | -27.3 | -41.5 | -45.2 | -30.3 | -21.2 |
| Investing cash flow | -137 | -98.9 | -80.6 | -65.1 | -52.0 | -34.2 | -42.0 | -49.2 | -44.9 | -33.8 |
| Financing cash flow | -18.8 | 4.3 | -10.1 | 3.4 | -31.2 | -6.0 | -11.0 | -9.5 | -1.0 | -9.1 |
| Dividends paid | -14.7 | -11.2 | -11.1 | -10.4 | — | — | — | -65.2 | -62.8 | — |
| Share repurchases | -6.2 | -4.8 | -3.9 | -2.9 | -1.2 | — | — | — | — | — |
| Debt issued | 85.3 | 71.2 | 30.5 | 59.2 | 0.8 | 4.3 | — | 86.3 | 64.9 | 4.8 |
| Debt repaid | -83.2 | -50.9 | -25.6 | -42.4 | -30.8 | -10.4 | -32.2 | -31.3 | -3.1 | -11.0 |
| Effect of exchange rates | 4.7 | -1.8 | 4.1 | 0.0 | 1.5 | 1.5 | 3.9 | 0.9 | -1.2 | -0.0 |
| Net change in cash | 1.6 | 10.8 | -11.5 | 11.9 | -27.7 | 20.8 | -6.5 | 8.6 | 4.4 | 13.4 |
| Free cash flow | 29.7 | 17.9 | 5.5 | 15.1 | 7.6 | — | — | — | — | — |
| Levered free cash flow | -33.6 | -15.6 | -35.1 | -7.8 | -19.0 | 27.2 | -10.2 | -7.7 | 18.5 | — |
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 55.7 | 79.7 | 73.0 | 65.3 | 41.8 | 37.7 | 37.5 | 42.4 | 31.1 | 38.5 |
| Depreciation and amortization | 42.4 | 30.0 | 36.4 | 25.1 | 32.0 | 21.7 | 28.1 | 18.8 | 24.3 | 16.8 |
| Capital expenditure | -69.7 | -67.4 | -55.5 | -40.3 | -49.0 | -32.2 | -37.4 | -23.6 | -34.8 | -25.3 |
| Investing cash flow | -74.3 | -72.5 | -64.4 | -44.8 | -54.0 | -37.8 | -42.8 | -28.9 | -36.2 | -28.0 |
| Financing cash flow | 20.6 | -11.5 | -7.3 | -6.9 | 11.2 | -10.7 | 0.5 | -5.1 | 8.5 | -23.2 |
| Dividends paid | -24.0 | 0.0 | -14.7 | 0.0 | -11.2 | -0.5 | -10.6 | 0.0 | -10.4 | — |
| Share repurchases | -2.5 | -5.4 | -0.8 | -4.0 | -0.7 | -3.6 | -0.3 | -1.8 | -1.1 | -1.0 |
| Debt issued | 76.0 | 68.3 | 17.0 | 34.0 | 37.2 | 0.9 | 29.6 | 25.4 | 33.7 | 0.8 |
| Debt repaid | -28.8 | -74.3 | -8.9 | -36.8 | -14.1 | -7.5 | -18.2 | -28.8 | -13.6 | -23.1 |
| Effect of exchange rates | 0.8 | 4.3 | 0.5 | 1.6 | -3.4 | 3.9 | 0.2 | 1.6 | -1.6 | 1.8 |
| Net change in cash | 2.8 | -0.0 | 1.7 | 15.2 | -4.4 | -6.9 | -4.6 | 10.0 | 1.8 | -10.9 |
| Free cash flow | -14.0 | 12.3 | 17.4 | 25.0 | -7.2 | 5.4 | 0.0 | 18.8 | -3.7 | 13.2 |
| Levered free cash flow | -41.0 | -3.8 | -28.7 | 1.7 | -17.2 | -12.8 | -22.4 | 13.6 | -21.3 | -0.1 |
Financial statements of similar companies
Companies in the group: same industry, similar size
